Dashboard

Solid News

Johnson & Johnson Correction within the Local Ascending Channel

12/15/2022 2:23 PM

Shares of Johnson & Johnson, one of the world's leading retail holdings, are correcting at 179.70.

Earlier this month, it became known that Johnson & Johnson was suing pharmaceutical giant Amgen Inc. because of a new drug for ulcerative colitis that the corporation believes is a copy of their most successful drug, Sterla, which accounted for 9.1B dollars of total sales of 52.0B dollars this year. Johnson & Johnson accuses competitors of failing to comply with several legal procedures when creating analogs of the drug, but the trial will take place as early as next year. Meanwhile, Amgen Inc. beat a division of Johnson & Johnson to win the right to purchase Horizon Therapeutics Public Ltd. Co for 27.8B dollars.

The dividend payment occurred on December 6, when shareholders received 1.13 dollars per share, which amounted to 2.57% per annum. The financial report will be released on January 24 and is projected to generate a profit of 23.91B dollars, up from 23.79B dollars last quarter.


On the daily chart of the asset, the trading instrument is correcting within the local ascending channel, approaching the resistance line.

Technical indicators keep a buy signal: fast EMAs on the Alligator indicator are above the signal line, and the AO oscillator histogram forms upward bars.

Resistance levels: 181.00, 185.00. | Support levels: 178.00, 173.00.

Find Us
Registered Address : Bonovo Road – Fomboni Island of Mohéli – Comoros Union
Sofia, PO Box 1407,14 Flip Kutev Str. Floor 2, Industrial area Hladilnika, Bulgaria
Mail Us
[email protected]
Call Us
+35 924 928 392


Risk Warnings
Solid ECN Securities LLC offers trading on Foreign Exchange (‘Forex’ or ‘FX’) and Contracts for Difference (‘CFDs’), which are complex financial products that are traded on margin. They carry a high level of risk since leverage can work both to your advantage and disadvantage. As a result, these products may not be suitable for all investors, as loss of all invested capital may occur. You should not risk more than you are prepared to lose. Before deciding to trade, you need to ensure that you understand the risks involved and consider your investment objectives and level of experience. Seek independent advice, if necessary.
Solid ECN Securities LLC does not issue advice, recommendations or opinions in relation to acquiring, holding or disposing of a CFD. Solid ECN Securities LLC is not a financial advisor and all services are provided on an execution-only basis. This communication is not an offer or solicitation to enter into a transaction and shall not be construed as such.
This website is not directed at any jurisdiction and is not intended for any use that would be contrary to local law or regulation.
By using solidecn.com you agree to use our cookies to enhance your experience.
Solid ECN Securities LLC is authorized and regulated by the Comoros Union with reference number HY00623411.
Disclaimer 1: The information provided on this site is not intended for residents of any country or jurisdiction where its distribution or use would violate local laws or regulations.
Disclaimer 2: Solid ECN Securities LLC and it affiliates does not provide services to residents of the USA, Japan, Canada, Australia, the Democratic Republic of Korea, European Union, United Kingdom, Iran, Syria, Sudan and Cuba.
Copyright All Right Reserved 2024 SolidECN.com